Therapeutic Aspects of Catechin and Its Derivatives – an Update

Total Page:16

File Type:pdf, Size:1020Kb

Therapeutic Aspects of Catechin and Its Derivatives – an Update ABMJ 2019, 2(1): 21-29 DOI: 10.2478/abmj-2019-0003 Acta Biologica Marisiensis THERAPEUTIC ASPECTS OF CATECHIN AND ITS DERIVATIVES – AN UPDATE Sanda COȘARCĂ1, Corneliu TANASE1*, Daniela Lucia MUNTEAN1 1University of Medicine, Pharmacy, Science and Technology of Târgu-Mureș, Faculty of Pharmacy, 38 Gheorghe Marinescu Street. *Correspondence: Corneliu TANASE [email protected] Received: 1 May 2019; Accepted: 20 June 2019; Published: 30 Iune 2019 Abstract: Catechin and its derivatives are polyphenolic benzopyran compounds. The condensation of catechin units leads to the formation of condensed tannins. It is found in appreciable amount in green tea leaves, cocoa, red wines, beer, chocolate, etc. It possesses important antioxidant, antibacterial, antifungal, antidiabetic, anti-inflammatory, antiproliferative and antitumor properties. The present review outlines recent updates and perspectives of the effects of catechins and the pharmacodynamic mechanisms involved. Keywords: catechin, antitumor, antioxidant, antibacterial, hypolipidemic. 1. Introduction Catechins are flavanols which belong to catechins have an important role in protection polyphenolic compounds. Condensed or non- against degenerative diseases (Ide et al., 2018). hydrolyzable tannins are formed by the Other studies have demonstrated an inverse condensation of catechin (epicatechin and a reaction between catechin intake and the risk of catechin epimer) (Fig. 1). Catechin, together cardiovascular diseases (Ikeda et al., 2018). It with epicatechin and epigallocatechin gallate, has been reported that catechins appear to are the main flavonoids which are found in the produce greater antibacterial activity against composition of green tea (Li et al., 2018). Gram-positive bacteria than Gram-negative Many research results have highlighted that ones (Ajiboye et al., 2016; Gomes et al., 2018). Fig. 1. Chemical structure of catechin and its derivatives 21 Sanda Coșarcă et al. The present paper is a critical review of the several antioxidant, antihypertensive, anti- recent literature on therapeutic aspects and inflammatory, antithrombogenic, hypo- pharmacodynamic mechanisms of catechin and lipidemic, etc. effects (Rothwell et al., 2018). It its derivatives. was also shown that catechin and its derivatives, namely epigallocatechin gallate, 2. Bioavailability and biological effects would inhibit platelet aggregation. These of catechin and its derivatives effects were explained by the inhibition of The bioavailability of catechin and its cytoplasmic calcium growth (Lill et al., 2003; derivatives differs significantly depending on Watson et al., 2014). Catechins also have an the form under which it is found (Table 1). important role in maintaining homeostasis When administered in esterified form with (Matsui, 2015), their cardioprotective and gallic acid, the absorption is much slower. antidiabetic effects have been demonstrated by Methylated forms were identified as a result of several studies (Thielecke et Boschmann, 2009; metabolization in the case of epigallocatechin. Hashemipour et al. 2017). In another study, the plasma concentration of 4’-O-methyl-epigallocatechin was determined, 3. Antiallergic properties whose value was 5 times higher in plasma and New studies have been conducted on the 3 times higher in urine than the concentration anti-inflammatory and anti-allergic effects of of epigallocatechin (Rothwell et al., 2018). catechin (Hussein et al., 2015). The Epigallocatechin gallate is the only flavonol pharmacological effects of catechin in mice form which is present in plasma in a significant with allergic rhinitis were determined by percentage (48-55%). performing haematoxylin and eosin staining The other catechins are detected as the and Giemsa staining of the nasal tissues glucoronidated or sulphated form. The main essential in observing the allergic symptoms. epicatechin metabolites are: epicatechin-3’-O- The results showed that catechin, at 75, 150 or glucuronide, 4’-O-methylepicatechin-3’-O- 300 mg/kg bodyweight, reduced the allergic glucuronide, 4’-O-methyl-epicatechin-5- or 7- symptoms in mice with allergic rhinitis, such as O-glucuronide, 4’-O-methylepicatechine and sneezing and nasal rubbing. Catechin could epicatechin aglycone (Liao et al., 2018; reduce interleukin-5, interleukin-13 and Casanova et al., 2019). Metabolization leads to ovalbumin E serum concentrations and restore metabolites that can extend the beneficial effect T helper type 2 / T helper type 1 cell balance. of catechins, having a longer half-life (5 hours Catechin has efficiently decreased the for epigallocatechin-3-gallate). In this case, inflammation in allergic rhinitis. The renal excretion of catechins is very rapid mechanism of action would be that catechin (Manach et al., 2005; Ikeda et al., 2018). inhibited the expression of TSLP (lymphatic Catechin influences molecular mechanisms stromal lymphopoietin) in epithelial cells by involved in angiogenesis, extracellular matrix influencing the NF-κB / TSLP pathway (Pan et degradation, regulation of cell motility, and al., 2018). multiple resistance to cancers and associated disorders. 4. Cardiovascular effects Based on epidemiological and Recent evidence demonstrates that experimental studies, a correlation between catechins can be key mediators in green tea consumption rich in catechins and cardiovascular health through mechanisms cardiovascular health has been highlighted by underlying blood pressure reduction, 22 ABMJ 2019, 2(1): 21-29 vasodilation, and atherosclerosis (Mangels et al., 2012) processes. Generation of ROS in al, 2017). neuronal cells activates inflammatory The prevalence of coronary heart disease mediators like TNF-α, COX-2, NF-κβ as well in Asian people is demonstrated to be very low as proapoptotic mediators such as Bcl-2 and due to their increased tea consumption (Shahid caspase-9 (Suryavanshi et al, 2017; Kimura- et al., 2016; Li et al., 2018). Also, recent Ohba et al., 2016). Catechin directly or studies have demonstrated that, due to their indirectly decreases neuronal damage by antioxidant effect, they have the ability to reducing oxidative stress, scavenging ROS and reduce cytotoxicity produced by amiodarone improving antioxidant enzymes (Shai et al (commonly used antiarrhythmic drug) in 2015; Xiang et al., 2016). human lung fibroblast cells (Cooper et al., 2005; Santos et al., 2017). 6. Lipid-lowering effects Studies in rats have shown that catechin in 5. Antioxidant and anti-tumor effect green tea can reduce the risk of cardiovascular Clinical trials conducted so far have shown disease (CD). The effect has been attributed to the beneficial effects of catechin due to its the antioxidant and anti-inflammatory antioxidant action. The ability of catechins to properties of catechin. Also it is suggested that cross the blood-brain barrier has led to catechin reduces the risk of cardiovascular increased interest related to their antioxidant disease by lowering cholesterol and triglyceride properties beneficial for the prevention and levels (Cooper et al., 2005). In vitro and in vivo treatment of neurodegenerative diseases. studies show that catechins in green tea inhibit Catechin and other catechins in green tea intestinal absorption of dietary lipids, by block carcinogenesis and help modulate signal interfering with lipid digestion and their transduction pathways related to proliferation, solubilization (the critical steps involved in the transformation, inflammation and metastasis of intestinal absorption of dietary fats, cholesterol cells. It also has a chemopreventive potential and other lipids). Based on the information (Grzesik et al, 2018; Yang et al., 2018; available so far, it is clear that green tea and its Baranowska et al., 2018) and catechin catechins effectively reduce the intestinal nanohybrids significantly improve the anti- absorption of lipids (Ikeda et al., 1992). The tumour effect by inducing apoptosis of WM266 mechanism of action of catechin is based on the human melanoma versus free catechin (Di Leo fact that it inhibits the absorption of lipids. This et al., 2017). Also, the loading of catechin with effect appears to be associated with its ability PLGA (poly (1-lactide-co-glycolide)) fibers to form complexes with lipids and lipolytic had a high effect of reducing the reactive enzymes, thereby interfering with oxygen species, so processing of catechin in emulsification, hydrolysis, micellar controlled release forms could allow future solubilization processes and subsequent localized applications of great importance in absorption of lipids. These mechanisms are not the fields of tissue engineering and wound fully clarified and further studies are needed to healing (Ghitescu et al., 2018). define mechanisms underlying lipid absorption Oxidative stress plays a central role in the inhibition (Shishikura et al.; 2006; Koo et al., degeneration of neurons by activating 2007). intracellular signaling cascades, which have a role in autoimmune apoptosis and extracellular modulation (Suryavanshi et al, 2017, Bhatt et 23 Sanda Coșarcă et al. 7. Antibacterial and antiviral effect Polyphenols are among the most abundant been reported to be associated with a number of compounds in the plant kingdom. They have organoleptic properties of drinks and foods. Table 1. The effect of catechin and its derivates Compound Effect Reference epicatechin gallate beneficial role in muscles Kim AR et al.,2017 epigallocatechin-3-gallate regeneration epigallocatechin, antioxidant Ikeda et al., 2018 epicatechin, cardioprotective
Recommended publications
  • INVESTIGATION of NATURAL PRODUCT SCAFFOLDS for the DEVELOPMENT of OPIOID RECEPTOR LIGANDS by Katherine M
    INVESTIGATION OF NATURAL PRODUCT SCAFFOLDS FOR THE DEVELOPMENT OF OPIOID RECEPTOR LIGANDS By Katherine M. Prevatt-Smith Submitted to the graduate degree program in Medicinal Chemistry and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. _________________________________ Chairperson: Dr. Thomas E. Prisinzano _________________________________ Dr. Brian S. J. Blagg _________________________________ Dr. Michael F. Rafferty _________________________________ Dr. Paul R. Hanson _________________________________ Dr. Susan M. Lunte Date Defended: July 18, 2012 The Dissertation Committee for Katherine M. Prevatt-Smith certifies that this is the approved version of the following dissertation: INVESTIGATION OF NATURAL PRODUCT SCAFFOLDS FOR THE DEVELOPMENT OF OPIOID RECEPTOR LIGANDS _________________________________ Chairperson: Dr. Thomas E. Prisinzano Date approved: July 18, 2012 ii ABSTRACT Kappa opioid (KOP) receptors have been suggested as an alternative target to the mu opioid (MOP) receptor for the treatment of pain because KOP activation is associated with fewer negative side-effects (respiratory depression, constipation, tolerance, and dependence). The KOP receptor has also been implicated in several abuse-related effects in the central nervous system (CNS). KOP ligands have been investigated as pharmacotherapies for drug abuse; KOP agonists have been shown to modulate dopamine concentrations in the CNS as well as attenuate the self-administration of cocaine in a variety of species, and KOP antagonists have potential in the treatment of relapse. One drawback of current opioid ligand investigation is that many compounds are based on the morphine scaffold and thus have similar properties, both positive and negative, to the parent molecule. Thus there is increasing need to discover new chemical scaffolds with opioid receptor activity.
    [Show full text]
  • Impact of Using Organic Yeast in the Fermentation Process of Wine
    processes Article Impact of Using Organic Yeast in the Fermentation Process of Wine Balázs Nagy 1, Zsuzsanna Varga 2,Réka Matolcsi 1, Nikolett Kellner 1 , Áron Szövényi 1 and Diána Nyitrainé Sárdy 1,* 1 Faculty of Horticultural Science Department of Oenology, Szent István University, 1118 Budapest, Hungary; [email protected] (B.N.); [email protected] (R.M.); [email protected] (N.K.); [email protected] (Á.S.) 2 Faculty of Horticultural Science Department of Viticulture, Szent István University, 1118 Budapest, Hungary; [email protected] * Correspondence: [email protected] Abstract: The aim of this study was to find out what kind of “Bianca” wine could be produced when using organic yeast, what are the dynamics of the resulting alcoholic fermentation, and whether this method is suitable for industrial production as well. Due to the stricter rules and regulations, as well as the limited amount and selection of the permitted chemicals, resistant, also known as interspecific or innovative grape varieties, can be the ideal basic materials of alternative cultivation technologies. Well-designed analytical and organoleptic results have to provide the scientific background of resistant varieties, as these cultivars and their environmentally friendly cultivation techniques could be the raw materials of the future. The role of the yeast in wine production is crucial. We fermented wines from the “Bianca” juice samples three times where model chemical solutions were applied. In our research, we aimed to find out how organic yeast influenced the biogenic amine formation of three important compounds: histamine, tyramine, and serotonin. The main results of this study showed that all the problematic values (e.g., histamine) were under the critical limit (1 g/L), although the organic samples resulted in a significantly higher level than the control wines.
    [Show full text]
  • Crofelemer Oral Delayed Release Tablet
    Contains Nonbinding Recommendations Draft – Not for Implementation Draft Guidance on Crofelemer This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA, or the Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the Office of Generic Drugs. Active Ingredient: Crofelemer Dosage Form; Route: Tablet, delayed release; oral Strength: 125 mg Recommendations for the Assessment of Identity and Quality of Botanical Raw Material (BRM): Crofelemer is a botanical drug derived from BRM, the crude red latex of Croton lechleri Müll. Arg. [Fam. Euphorbiacae], which is also called dragon’s blood (sangre de drago). Generic drug applicants should use the same plant species and perform BRM assessment: 1. Crofelemer BRM should be collected from the crude red latex of Croton lechleri. The plant species should be correctly identified and authenticated based on techniques such as macroscopic/microscopic and/or analysis of genetic material. 2. Crude red latex as BRM should be collected from the mature tree with defined eco- geographic regions (EGRs). Implementing and enforcing established good agricultural and collection practice (GACP) procedures will minimize variations in BRM and ensure batch- to-batch consistency of crofelemer. 3. BRMs should be analyzed for their crofelemer content, total phenolics and taspine content, as well as heavy metals and pesticides. Recommendations for Demonstrating API Sameness: API sameness can be established by showing equivalence between Test API and API from the reference listed drug (RLD) product with the three criteria described in detail below.
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • Management of Chronic Problems
    MANAGEMENT OF CHRONIC PROBLEMS INTERACTIONS BETWEEN ALCOHOL AND DRUGS A. Leary,* T. MacDonald† SUMMARY concerned. Alcohol may alter the effects of the drug; drug In western society alcohol consumption is common as is may change the effects of alcohol; or both may occur. the use of therapeutic drugs. It is not surprising therefore The interaction between alcohol and drug may be that concomitant use of these should occur frequently. The pharmacokinetic, with altered absorption, metabolism or consequences of this combination vary with the dose of elimination of the drug, alcohol or both.2 Alcohol may drug, the amount of alcohol taken, the mode of affect drug pharmacokinetics by altering gastric emptying administration and the pharmacological effects of the drug or liver metabolism. Drugs may affect alcohol kinetics by concerned. Interactions may be pharmacokinetic or altering gastric emptying or inhibiting gastric alcohol pharmacodynamic, and while coincidental use of alcohol dehydrogenase (ADH).3 This may lead to altered tissue may affect the metabolism or action of a drug, a drug may concentrations of one or both agents, with resultant toxicity. equally affect the metabolism or action of alcohol. Alcohol- The results of concomitant use may also be principally drug interactions may differ with acute and chronic alcohol pharmacodynamic, with combined alcohol and drug effects ingestion, particularly where toxicity is due to a metabolite occurring at the receptor level without important changes rather than the parent drug. There is both inter- and intra- in plasma concentration of either. Some interactions have individual variation in the response to concomitant drug both kinetic and dynamic components and, where this is and alcohol use.
    [Show full text]
  • Green Tea Extract Ameliorate Liver Toxicity and Immune System Dysfunction Induced by Cyproterone Acetate in Female Rats
    Journal of American Science 2010;6(5) Green Tea Extract Ameliorate Liver Toxicity and Immune System Dysfunction Induced by Cyproterone Acetate in Female Rats Heba Barakat Department of Biochemistry and Nutrition,Women`s College, Ain Shams University [email protected] Abstract: Green tea, consumed worldwide since ancient times, is considered beneficial to human health. The present study aimed to evaluate the effect of green tea extract (GTE) on liver damage and immune system function in female rats treated with cyproterone acetate (CPA). Forty healthy female adult albino rats were randomly assigned to four groups. Group (1) was fed on a standard diet as a control. Group (2) was fed on a standard diet and received an intraperitoneally injection of 25mg/Kg/day. Group (3) was fed on a standard diet supplemented with 1 g GTE% and received a daily injection. Group (4) was fed on the supplemented diet for 7 days prior to receiving the daily injection. The experimental duration lasted for 3 weeks initiated from the first injection. The results showed CPA alone led to diminish liver function, hepatic antioxidant enzyme activities and elevated hepatic oxidative stress and serum IgG and IgM levels comparing with the control group of rats. However, the ingestion of GTE either along with or prior to the CPA treatment could significantly improve the function of liver, hepatic oxidative stress and hepatic antioxidant status and elevate the IgG and IgM levels. These data suggested that, GTE possesses a protective effect on the liver against the induced CPA toxicity by increasing auto immunity and countering the hepatic oxidative stress.
    [Show full text]
  • Antidepressant-Like Behavioral and Neurochemical Effects of the Citrus
    Available online at www.sciencedirect.com Life Sciences 82 (2008) 741–751 www.elsevier.com/locate/lifescie Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin ⁎ Li-Tao Yi, Jian-Mei Li, Yu-Cheng Li, Ying Pan, Qun Xu, Ling-Dong Kong State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, PR China Received 14 July 2007; accepted 16 January 2008 Abstract Apigenin is one type of bioflavonoid widely found in citrus fruits, which possesses a variety of pharmacological actions on the central nervous system. A previous study showed that acute intraperitoneal administration of apigenin had antidepressant-like effects in the forced swimming test (FST) in ddY mice. To better understand its pharmacological activity, we investigated the behavioral effects of chronic oral apigenin treatment in the FST in male ICR mice and male Wistar rats exposed to chronic mild stress (CMS). The effects of apigenin on central monoaminergic neurotransmitter systems, the hypothalamic–pituitary–adrenal (HPA) axis and platelet adenylyl cyclase activity were simultaneously examined in the CMS rats. Apigenin reduced immobility time in the mouse FST and reversed CMS-induced decrease in sucrose intake of rats. Apigenin also attenuated CMS-induced alterations in serotonin (5-HT), its metabolite 5-hydroxyindoleacetic acid (5-HIAA), dopamine (DA) levels and 5-HIAA/ 5-HT ratio in distinct rat brain regions. Moreover, apigenin reversed CMS-induced elevation in serum corticosterone concentrations and reduction in platelet adenylyl cyclase activity in rats. These results suggest that the antidepressant-like actions of oral apigenin treatment could be related to a combination of multiple biochemical effects, and might help to elucidate its mechanisms of action that are involved in normalization of stress- induced changes in brain monoamine levels, the HPA axis, and the platelet adenylyl cyclase activity.
    [Show full text]
  • What Is Old Is New…
    8/20/2015 WHAT’S COMING DOWN THE PIPELINE? NEWER AND FUTURE ANESTHETIC AND ANALGESIC DRUGS FOR THE SMALL ANIMAL PRACTITIONER. ANESTHESIA AND ANALGESIA Looking for the next “great” tool in the box New drugs and new uses for old drugs Improve patient care and maximize outcomes WHAT IS OLD IS NEW… Methadone Fentanyl (topical) Buprenorphine (transmucosal) Etomidate Meloxicam (transmucosal spray) Robenaxocib 1 8/20/2015 WHAT IS NEW IS NEW… Propoflo 28® (propofol with an increased shelf life) Remifentanil Alenza Simbadol™ ‐ Long acting buprenorphine Alfaxan®‐ CD (alfaxalone) METHADONE Pure µ agonist opioid (synthetic) NMDA antagonist May be best opioid for chronic pain Better analgesic than buprenorphine for 8 hours post operatively Less vomiting and panting than hydromorphone and morphine in dogs Does not seem to elicit aggressive behavior in cats Can be expensive, can not be administered orally (unlike in humans) Dosages Dogs 0.25 to 0.5 mg/kg, IM or IV Cats 0.1 mg/kg, IM or IV FENTANYL (TOPICAL) Recuvyra™ Transdermal solution Topical application in dogs only 50 mg/ml fentanyl (Class II controlled substance) Risk Minimization Action Plan (RiskMAP) Educational materials to veterinarian, staff and owners 2 8/20/2015 FENTANYL (TOPICAL) RiskMAP Owner must read and sign client information sheet before application Only available through a restricted distribution program Certified distributors Veterinarian must take online training prior to being able to purchase High potential for human abuse and safety risks FENTANYL (TOPICAL) Use Administered by two trained veterinarians or staff Protective clothing –gloves, lab coats, and glasses or face shield Applied directly to the skin in the dorsal scapular area.
    [Show full text]
  • Guideline for Preoperative Medication Management
    Guideline: Preoperative Medication Management Guideline for Preoperative Medication Management Purpose of Guideline: To provide guidance to physicians, advanced practice providers (APPs), pharmacists, and nurses regarding medication management in the preoperative setting. Background: Appropriate perioperative medication management is essential to ensure positive surgical outcomes and prevent medication misadventures.1 Results from a prospective analysis of 1,025 patients admitted to a general surgical unit concluded that patients on at least one medication for a chronic disease are 2.7 times more likely to experience surgical complications compared with those not taking any medications. As the aging population requires more medication use and the availability of various nonprescription medications continues to increase, so does the risk of polypharmacy and the need for perioperative medication guidance.2 There are no well-designed trials to support evidence-based recommendations for perioperative medication management; however, general principles and best practice approaches are available. General considerations for perioperative medication management include a thorough medication history, understanding of the medication pharmacokinetics and potential for withdrawal symptoms, understanding the risks associated with the surgical procedure and the risks of medication discontinuation based on the intended indication. Clinical judgement must be exercised, especially if medication pharmacokinetics are not predictable or there are significant risks associated with inappropriate medication withdrawal (eg, tolerance) or continuation (eg, postsurgical infection).2 Clinical Assessment: Prior to instructing the patient on preoperative medication management, completion of a thorough medication history is recommended – including all information on prescription medications, over-the-counter medications, “as needed” medications, vitamins, supplements, and herbal medications. Allergies should also be verified and documented.
    [Show full text]
  • Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction
    pharmaceutics Review Potential Herb–Drug Interactions in the Management of Age-Related Cognitive Dysfunction Maria D. Auxtero 1, Susana Chalante 1,Mário R. Abade 1 , Rui Jorge 1,2,3 and Ana I. Fernandes 1,* 1 CiiEM, Interdisciplinary Research Centre Egas Moniz, Instituto Universitário Egas Moniz, Quinta da Granja, Monte de Caparica, 2829-511 Caparica, Portugal; [email protected] (M.D.A.); [email protected] (S.C.); [email protected] (M.R.A.); [email protected] (R.J.) 2 Polytechnic Institute of Santarém, School of Agriculture, Quinta do Galinheiro, 2001-904 Santarém, Portugal 3 CIEQV, Life Quality Research Centre, IPSantarém/IPLeiria, Avenida Dr. Mário Soares, 110, 2040-413 Rio Maior, Portugal * Correspondence: [email protected]; Tel.: +35-12-1294-6823 Abstract: Late-life mild cognitive impairment and dementia represent a significant burden on health- care systems and a unique challenge to medicine due to the currently limited treatment options. Plant phytochemicals have been considered in alternative, or complementary, prevention and treat- ment strategies. Herbals are consumed as such, or as food supplements, whose consumption has recently increased. However, these products are not exempt from adverse effects and pharmaco- logical interactions, presenting a special risk in aged, polymedicated individuals. Understanding pharmacokinetic and pharmacodynamic interactions is warranted to avoid undesirable adverse drug reactions, which may result in unwanted side-effects or therapeutic failure. The present study reviews the potential interactions between selected bioactive compounds (170) used by seniors for cognitive enhancement and representative drugs of 10 pharmacotherapeutic classes commonly prescribed to the middle-aged adults, often multimorbid and polymedicated, to anticipate and prevent risks arising from their co-administration.
    [Show full text]
  • Catechin Attenuates Behavioral Neurotoxicity Induced by 6-OHDA in Rats
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Pharmacology, Biochemistry and Behavior 110 (2013) 1–7 Contents lists available at ScienceDirect Pharmacology, Biochemistry and Behavior journal homepage: www.elsevier.com/locate/pharmbiochembeh Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats M.D.A. Teixeira a, C.M. Souza a, A.P.F. Menezes a, M.R.S. Carmo a, A.A. Fonteles a, J.P. Gurgel a, F.A.V. Lima b, G.S.B. Viana b, G.M. Andrade a,⁎ a Laboratory of Neurosciences and Behavior, Federal University of Ceará, Rua Cel. Nunes de Melo, 1127, Fortaleza 60430270, Brazil b Laboratory of Neuropharmacology, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Rua Cel. Nunes de Melo, 1127, Fortaleza 60430270, Brazil article info abstract Article history: This study was designed to investigate the beneficial effect of catechin in a model of Parkinson's disease. Received 18 February 2013 Unilateral, intrastriatal 6-hydroxydopamine (6-OHDA)-lesioned rats were pretreated with catechin (10 and Received in revised form 15 May 2013 30 mg/kg) by intraperitoneal (i.p.) injection 2 h before surgery and for 14 days afterwards. After treatments, Accepted 18 May 2013 apomorphine-induced rotations, locomotor activity, working memory and early and late aversive memories Available online 25 May 2013 were evaluated. The mesencephalon was used to determine the levels of monoamines and measurement of Keywords: glutathione (GSH). Immunohistochemical staining was also used to evaluate the expression of tyrosine Catechin hydroxylase (TH) in mesencephalic and striatal tissues.
    [Show full text]
  • 2 12/ 35 74Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 22 March 2012 (22.03.2012) 2 12/ 35 74 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 9/16 (2006.01) A61K 9/51 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 9/14 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP201 1/065959 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 14 September 201 1 (14.09.201 1) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, (25) Filing Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, (26) Publication Language: English TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/382,653 14 September 2010 (14.09.2010) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant (for all designated States except US): GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, NANOLOGICA AB [SE/SE]; P.O Box 8182, S-104 20 ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, Stockholm (SE).
    [Show full text]